March 15, 2021 Clinical Research/Diagn. Liq. Handling & Robotics M&A, Partnerships

Roche signs definitive merger agreement with GenMark Diagnostics, Inc., to access novel technology to test for broad range of pathogens with one patient sample

Basel, 15 March 2021 Roche to acquire GenMark Diagnostics for US$ 24.05 per share with the expectation to close in the 2nd quarter of 2021 GenMark provides molecular diagnostic tests that are designed to detect multiple pathogens from a single patient sample GenMark’s ePlex platform delivers rapid and actionable results so clinicians can determine the... Read more

March 2, 2021 Clinical Research/Diagn. M&A, Partnerships

Agilent to Acquire Resolution Bioscience, Strengthening Leadership Position in Cancer Diagnostics

SANTA CLARA, Calif., March 02, 2021  Highlights: Resolution Bioscience is a fast-growing, innovative leader in next-generation sequencing (NGS)-based oncology solutions. Combination brings together Resolution Bioscience’s noninvasive liquid biopsy platform that improves cancer diagnostics with Agilent’s leadership in tissue-based companion diagnostics and global commercial and regulatory scale. Furthers Agilent’s participation in fast-growing NGS technologies for precision... Read more

February 24, 2021 Life Science Tools M&A, Partnerships

10x Genomics Showcases Next Wave of Innovations at First Ever Xperience Event

Acquires Tetramer Shop; Reveals Details on Upcoming Products PLEASANTON, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) — 10x Genomics, Inc. (Nasdaq: TXG) today detailed a slew of new products and announced the acquisition of Copenhagen-based Tetramer Shop at its inaugural Xperience 2021 event, a showcase with three breakout sessions corresponding to 10x’s three product platforms:  Chromium Single... Read more

February 24, 2021 Clinical Research/Diagn. Lab Top-10 Life Science Tools M&A, Partnerships

QIAGEN and INOVIO expand collaboration to develop next generation sequencing (NGS) companion diagnostic for INOVIO’s VGX-3100 for advanced cervical dysplasia

PLYMOUTH MEETING, PA., USA, and GERMANTOWN, MD., USA, and HILDEN, Germany, February 24, 2021 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and INOVIO Pharmaceuticals (NASDAQ: INO) today announced an extension of their partnership with a new master collaboration agreement to develop liquid biopsy-based companion* diagnostic products based on next-generation sequencing (NGS) technology to complement... Read more

February 23, 2021 M&A, Partnerships Materials Analysis

Microtrac MRB Signs Exclusive Distributor Agreement With OleiniTec Nordic AB

Microtrac MRB and OleiniTec Nordic AB are announcing today that they have entered into an exclusive Distribution Agreement for OleinitTec to distribute the CAMSIZER product line by MICROTRAC in Sweden and Finland.  This adds to the MICROTRAC laser diffraction, dynamic light scattering and gas adsorption products OleiniTec has already been distributing in the region. “Adding the... Read more

February 23, 2021 Clinical Research/Diagn. M&A, Partnerships

Bio-Techne and Luminary Therapeutics Sign License Agreement for Use of Bio-Techne’s TcBuster for the Development of Luminary’s CAR-T Cell Therapies

FEBRUARY 23, 2021 MINNEAPOLIS, Feb. 23, 2021 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced the signing of a license agreement with Luminary Therapeutics for the use of TcBuster™ for the manufacturing of gene-modified cell therapies. TcBuster is Bio-Techne’s proprietary non-viral transposon-based gene delivery system used to advance cell therapy manufacturing.   Under the terms of this agreement,... Read more

February 19, 2021 M&A, Partnerships Molecular Spectroscopy

HORIBA FRANCE SAS and GreenTropism SAS to Collaborate on Smart Solutions for Processing and Analysis of Spectroscopic Images

02/19/2021 Palaiseau, Saclay Campus, France – HORIBA and GreenTropism have signed, 4th January 2021, a collaboration agreement. The two companies will combine their technologies for the development and commercialization of smart solutions combining HORIBA’s spectroscopic and hyperspectral imaging and GreenTropism’s data processing methods enhanced and automated by Artificial Intelligence. This collaboration will allow their respective and... Read more

February 18, 2021 Lab Top-10 Licensing, IP, and Legal M&A, Partnerships

QIAGEN announces Digital Partner Program with five initial partnerships

Redwood City, California, and Hilden, Germany, February 18, 2021 – QIAGEN today announced the launch of the QIAGEN Digital Insights Partnership program for genomic vendors to leverage QIAGEN’s genomic content and analysis leadership to expand customer access and deliver extended genomic solutions for scientists and clinicians. The first group of five new partnerships involves DNAnexus,... Read more

February 16, 2021 Liq. Handling & Robotics M&A, Partnerships

SPT Labtech acquires BioMicroLab

Deal strategically expands SPT Labtech’s offering in sample management for life sciences  To download this image, please click here. Cambridge, UK – 16 February 2021 – SPT Labtech, a global leader in the design and development of automated instrumentation and consumables for life science applications, announces the acquisition of BioMicroLab, a robotics automation provider for life science laboratories. Headquartered... Read more